GreenLight Biosciences Holdings, PBC Quarterly Revenues in USD from Q1 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
GreenLight Biosciences Holdings, PBC quarterly/annual Revenues history and growth rate from Q1 2021 to Q1 2023.
  • GreenLight Biosciences Holdings, PBC Revenues for the quarter ending March 31, 2023 was $3.82M, a 1386% increase year-over-year.
  • GreenLight Biosciences Holdings, PBC Revenues for the twelve months ending March 31, 2023 was $10.3M, a 577% increase year-over-year.
  • GreenLight Biosciences Holdings, PBC annual Revenues for 2022 was $6.78M, a 325% increase from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $10.3M $3.82M +$3.56M +1386% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $6.78M $3.02M +$2.61M +628% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 $4.17M $1.73M +$1.37M +378% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $2.8M $1.77M +$1.28M +259% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.53M $257K -$68K -20.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.6M $415K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 $362K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $493K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $325K Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-06-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.